Last reviewed · How we verify
NCT06179745
BCI Driving FES and Hand Orthosis for Upper Limb Rehabilitation in Chronic Stroke
NA trial testing EEG-based brain-computer interface in Stroke, Cerebrovascular in 32 participants. Status unknown.
31 March 2025
Quick facts
| Lead sponsor | University of Essex |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 32 |
| Start date | 14 March 2022 |
| Primary completion | 31 March 2025 |
| Estimated completion | 31 March 2025 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- EEG-based brain-computer interface
- Sham EEG-based brain-computer interface
- Functional Electrical Stimulation
- Active hand orthosis
Conditions studied
- Stroke, Cerebrovascular — all drugs for Stroke, Cerebrovascular →
- Hemiplegia and Hemiparesis — all drugs for Hemiplegia and Hemiparesis →
- Stroke/Brain Attack — all drugs for Stroke/Brain Attack →
Sponsor
University of Essex
Who can join
18 and older, any sex, with Stroke, Cerebrovascular or Hemiplegia and Hemiparesis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Multi-center, randomized, sham-controlled, double-blind, longitudinal, experimental clinical study to investigate functional recovery effects on the upper limb in chronic stroke patients and the accompanying neural plasticity mechanisms after the application of a brain-computer interface (BCI)-driven functional electrical stimulation (FES) therapy supported by an assistive device (hand orthosis). All the equipment used during the study will be applied in compliance with the indications and methods of use for which it is authorized. Therefore, the results will not extend the indications for the use of the equipment and will not explicitly target industrial development. The study is non-profit and is aimed at improving clinical practice. The study involves two clinical centers. The promoting center is the Vipiteno Neurorehabilitation Department, Italy. The aggregate experimentation center is the Neurology Department of Hochzirl Hospital, Austria. The University of Essex, United Kingdom is the technology provider and data analysis center.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06179745
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Stroke, Cerebrovascular
Currently open trials in the same condition.
- NCT06127602 — The REACTplusNMES Trial: A Double-blinded RCT · NA · recruiting
- NCT05443633 — Enhancing Language Function in Aphasia · NA · recruiting
Other University of Essex trials
Trials by the same sponsor.
- NCT05238428 — Understanding and Overcoming the Racial/Ethnic Inequalities in COVID-19 Vaccination Acceptance · NA · completed
- NCT07532967 — Optimizing Weblinks Used in Digital Vaccination Invitations to Raise Trust and Booking Intention: Online Experiment 2 · NA · completed
- NCT07516600 — Optimizing Weblinks Used in Digital Vaccination Invitations to Raise Trust and Booking Intention: Online Experiment 1 · NA · completed
- NCT05105269 — Managing Achilles Pain II · unknown
- NCT03035110 — A Feasibility Study to Evaluate Self-Harm Group in Inpatient Settings · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06179745 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Essex
- Last refreshed: 22 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06179745.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing